A detailed history of Gardner Lewis Asset Management L P transactions in Novo Nordisk A S stock. As of the latest transaction made, Gardner Lewis Asset Management L P holds 18,995 shares of NVO stock, worth $1.95 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
18,995
Previous 18,995 -0.0%
Holding current value
$1.95 Million
Previous $2.71 Million 16.6%
% of portfolio
0.64%
Previous 0.79%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $608,028 - $727,939
4,955 Added 35.29%
18,995 $2.71 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $1.43 Million - $1.91 Million
14,040 New
14,040 $1.8 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Gardner Lewis Asset Management L P Portfolio

Follow Gardner Lewis Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gardner Lewis Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Gardner Lewis Asset Management L P with notifications on news.